The present invention provides a DNA vaccine composition for preventing and treating herpes zoster, containing: at least one type of plasmid containing the insertion site of a varicella-zoster virus (VZV)-derived gene encoding a VZV protein and other pharmaceutically acceptable ingredients. The plasmid contains a plurality of plasmids containing the insertion site of heterologous genes which are different from each other. The plasmid contains: a first plasmid containing the insertion site of a first gene encoding IE-62 protein (SEQ ID NO: 1) a second plasmid containing the insertion site of a second gene encoding IE-63 protein (SEQ ID NO: 2) and a third plasmid containing the insertion site of a third gene encoding gE protein (SEQ ID NO: 3).
